On November 4, Bruker rose 15.57% in Regular Trading, trading at $60.58/share, with turnover of $171 million.
The move followed the company’s latest quarterly results, which showed adjusted EPS of $0.56 versus the $0.42 consensus estimate, while revenue rose to $874.0 million from market expectations of about $868.8 million. Non-GAAP net income also increased from $0.45 per diluted share a year earlier.
Additional support came from a sharp improvement in cash generation, with third-quarter free cash flow of $96.7 million compared with negative $54.1 million a year earlier. However, Bruker also guided full-year revenue to $3.52 billion-$3.56 billion, with the low end below the $3.56 billion consensus view, indicating the rally was primarily tied to the earnings and cash flow beat rather than guidance.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments